Woman wins £30,000 compensation for being compared to Darth Vader
Comparing someone at work to the Star Wars villain Darth Vader is 'insulting' and 'upsetting', an employment tribunal has ruled.
A judge concluded that being told you have the same personality type as the infamous sci-fi baddie is a workplace 'detriment' – a legal term meaning harm or negative impact experienced by a person.
'Darth Vader is a legendary villain of the Star Wars series, and being aligned with his personality is insulting,' the employment judge Kathryn Ramsden said.
The tribunal's ruling came in the case of an NHS blood donation worker Lorna Rooke, who has won almost £30,000 after her co-worker took a Star Wars-themed psychological test on her behalf and told colleagues Rooke fell into the Sith Lord's category.
The tribunal found that the outcome of the online quiz reflected the colleague's perception of Rooke and it was 'little wonder' the NHS employee was upset by the result.
The tribunal, held in Croydon, south London, heard that in 2003 Rooke began working for the NHS Blood and Transplant service as a training and practice supervisor.
In August 2021, members of Rooke's team took a Star Wars themed Myers-Briggs questionnaire as a team-building exercise.
The Myers-Briggs Type Indicator sorts people into 16 categories based on how introverted they are, level of intuition, if they are led by thoughts or feelings and how they judge or perceive the world around them.
In the movie franchise, Vader is half human, half machine, and uses the 'dark side of the force' in his pursuit of his son Luke Skywalker and the Rebel Alliance – also featuring Han Solo, Princess Leia, Chewbacca and the droids C-3P0 and R2-D2.
Read More Listed financial adviser in £6.1m law firm deal
But in the personality test, the Darth Vader category was described as a 'very focused individual' who could bring teams together.
Rooke did not participate as she had to take a personal phone call but when she returned a colleague, Amanda Harber, had filled it out on her behalf and announced that she had the same personality type as Vader – real name Anakin Skywalker.
The supervisor told the tribunal this outcome made her feel unpopular and was one of the reasons for her resignation the following month.
Although the tribunal rejected her claim that the 'Darth Vader incident' had prompted her to leave it did find it counted as a 'detriment'.
Rooke won her case for detriment after a protected disclosure but lost claims for unfair dismissal, disability discrimination, and failure to make reasonable adjustments. She was awarded £28,989.61 in compensation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
30 minutes ago
- Newsweek
Traveler Says Us Food Is Making Them 'Sick,' Internet Has Strong Opinions
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. An American traveler's viral Reddit post about the stark contrast between food in the United States and Italy has ignited widespread discussion about diet, health and food quality in the U.S. The post, titled "Travel made me realize US food is making me sick," was shared by u/Temporary-Night-275 in the r/Vent subreddit. The post, which details the traveler's experience after returning from a trip to Italy, has amassed 30,000 upvotes and hundreds of comments since it was posted on June 4. The poster, who is in their 20s but did not share their name, told Newsweek that they live in the Midwest and work in health care. "I'm just so mad at the food in the US," the poster wrote. "I left for two weeks to Italy. My mood was better, my awareness was better. I could eat wheat (I'm extremely gluten intolerant and it messes with my autoimmune disease if I eat it among a multitude of other symptoms) with gluten pills with minor bloating. "I had some of the best food, best health feelings—other than muscle soreness from walking so much—I've ever had in my life. It's made me have so much resentment for U.S. food. I mean even my skin cleared up quite a bit overseas." Dr. Sandip Sachar, a New York City dentist with a background in nutrition studies, told Newsweek: "It is quite possible the Reddit poster's experience was accurate and has validity." Sachar explained: "Italy does not add fluoride to its public water supply. Unlike countries such as the United States, where water fluoridation is a public health measure to prevent tooth decay, Italy has never implemented artificial water fluoridation programs. "Despite not adding fluoride to its water supply, Italy does not have significantly higher caries [tooth decay] rates compared to the U.S. within similar socioeconomic populations." She added that diet and culture likely play a role: "Food isn't rushed or eaten on the go." A 2018 study in the American Journal of Lifestyle Medicine highlighted broader concerns about American dietary habits. The study said "that most chronic diseases that afflict Americans are predominantly lifestyle induced; and the belief is that the vast majority of heart attacks and strokes could be prevented if people were willing to adopt healthy lifestyle behaviors." The study noted: "Over the past 50 years, the health of Americans has gotten worse, and now 71 percent of Americans are overweight or obese…today, eating processed foods and fast foods may kill more people prematurely than cigarette smoking." Stock image of a table spread with various American-themed foods, including hot dogs, burgers and potato chips. Stock image of a table spread with various American-themed foods, including hot dogs, burgers and potato chips. Getty The traveler explained in the viral post: "I eat pretty healthy—I love snacking on veggies. It just makes me so mad that having any kind of sugar is just too much here [the U.S.]. Sugar and wheat and whatever else is just so much harder on my body here than Italy." The poster told of how was initially "too nervous" to try gluten while abroad, after not having had it in 10 years. However, when they did, the reaction was mild. The poster told Newsweek: "I didn't wake up the next day feeling like I got hit by a bus. I didn't have the skin irritation. I didn't have massive weight gain, just bloating and cramping. "When I took my gluten enzymes, it basically resolved the effects in a couple hours. And this was after eating pizza, bread and pasta. Everything I ate just tasted not only better, but just better quality. It's really hard to explain. I just could tell it was cleaner." Reflecting on life back in the U.S., the poster said: "Overall, since [my travels], I have adopted some foods from overseas and try to buy organic and imported [foods]. I have continued to feel better, but there's only so much I can do when organic costs more…all I can say there is definitely a difference in quality, taste and overall feeling from the foods I had [abroad]." Food in Italy vs. the US Sachar told Newsweek: "Italy's traditional Mediterranean diet is low in added sugars. It is high in fiber, healthy fats, like olive oil, and antioxidants. Generally speaking Italian food is based on more real, minimally processed food." She added: "In the U.S., high sugar and salt is found in everything from cereals to sauces. Sugar is fuel for Streptococcus mutans, the bacteria most responsible for tooth decay. Sugary foods also cause rapid glucose spikes, triggering a strong insulin response. "Over time, this can contribute to insulin resistance, fat storage, type 2 diabetes, heart disease, obesity and increased inflammation. Excess sugar also disrupts the gut microbiome." Comparing breads, Sachar said: "Italian bread is usually made with just three to four ingredients—flour, water, salt, and yeast." In contrast, much of American bread contains dough conditioners (e.g. azodicarbonamide), emulsifiers, added sugars or high-fructose corn syrup, preservatives to extend shelf life and synthetic vitamins (fortified), she said. Sachar noted that traditional Italian and European breads often undergo long fermentation (12 to 48 hours), making them easier to digest and reducing the glycemic index. "Most commercial breads in the U.S. do not go through this long fermentation process because speed is prioritized." Cultural attitudes toward food also differ significantly. "Meals in Italy are slower, social, and often cooked at home. Food isn't rushed or eaten on the go. Lunch breaks are usually one to two hours long. Children grow up learning better eating habits. Portions are smaller too. In the U.S., convenience and speed is considered a priority. Processed foods and takeout are therefore widespread," Sachar said. 'The Quality of Our Food Is Garbage' Reddit users responding to the viral post shared their own experiences of struggling with American food. "When I first moved to the U.S. I gained 60 whole ass pounds," wrote u/Ok_Profile_9278. "My habits didn't actually change much, but everyone I know who's come here from a different country has a similar story to tell." U/Platypus_31415 echoed this: "I spent three weeks in the U.S. and it took me three to four months to recover. It's the land of the free: free to sell crap to the customers." Another commenter, u/SureAd5625, pointed to a deeper problem: "The issue isn't even the type of food. It's what's in our food. Other countries have diets that are extremely carb heavy and you'll still see people that are skinny…and relatively healthier. The quality of our food is gaaaaarbage." Another noted that lifestyle plays a role. "It's also our very sedentary and car-dependent lifestyles," said u/Corguita. "When you walk and move more to get to places naturally, there's a whole lot of things that come with that. When you just drive from one place to another, you don't burn as many calories, you don't digest as well." Do you have a travel-related video or story to share? Let us know via life@ and your story could be featured on Newsweek.
Yahoo
4 hours ago
- Yahoo
Hornets players invite fans to sign up for special stair climb
Watford players are inviting people to join a special stair climbing event and help make a difference in the community. Vicarage Road Stadium will host the Step Up Challenge on July 5, coinciding with the 77th birthday of the NHS. Defenders James Morris and James Clarridge and midfielders Anna Filbey and Leo Ramirez-Espain are encouraging fans to participate. The event, open to football lovers, fitness aficionados, and families, will see participants walking, running, or climbing through the 20,000-plus seat stadium. The money raised will go towards enhancing the health and wellbeing of thousands of local residents through Watford FC's Community Sports and Education Trust and West Herts Hospitals Charity. The Step Up Challenge will take place on July 5, which coincides with the 77th birthday of the NHS. (Image: Watford FC Trust) Anna, who is ambassador for West Herts Hospitals Charity, said: "We're excited to invite fans to take part in the Step Up Challenge at Vicarage Road. "It's a fantastic way to support our local NHS hospitals and Watford FC's Community Trust, while celebrating 77 years of the NHS's incredible service." The funds generated will aid West Herts Hospitals Charity in its mission to enhance patient care and staff welfare across at Watford General, Hemel Hempstead and St Albans City hospitals. The charity recently funded a new 'Wellbeing Courtyard' at Watford General, providing patients with access to fresh air and a peaceful retreat for NHS staff to recharge. The Step Up Challenge is suitable for all, offering both a full and half route. The event is suitable for all, offering a full and half route. (Image: Watford FC Trust) There is a £15 registration fee for adults (18 years and over) and a £5 fee for young people (6–18 years). To join the challenge at Vicarage Road Stadium on Saturday, July 5, visit the registration link via The event is not only an opportunity for participants to challenge themselves but also a chance to contribute towards a vital cause, supporting healthcare in the local community. Whether you're a fitness enthusiast looking to set a new personal record or someone wanting to enjoy a unique challenge while supporting healthcare, the Step Up Challenge is an initiative that combines fitness, fun, and philanthropy. Join Watford FC players in this one-of-a-kind event and make a difference in the community.
Business Upturn
5 hours ago
- Business Upturn
HistoSonics and Cambridge University Unveil Europe's First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift
MINNEAPOLIS, United States: HistoSonics, the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, announced today that Addenbrookes Hospital of Cambridge University Hospital Foundation and Trust will be the first site in the United Kingdom and European continent to offer histotripsy to both NHS and private patients. This was made possible through a generous donation by the Li Ka Shing Foundation (LKSF) as well as the expedited limited market access granted by the MHRA in April 2025. This press release features multimedia. View the full release here: The milestone marks HistoSonics' official entry into the UK and European market. HistoSonics won a coveted place in the Innovative Device Access Pathway pilot in 2024 and through this program, in partnership with the DHSC, MHRA, NIHR, NHSE, and NICE expedited access to patients. HistoSonics will continue to work with UK healthcare stakeholders on our aligned goal of urgently expanding access for all NHS patients. The Li Ka Shing Foundation, established in 1980 by Hong Kong philanthropist Sir Ka-shing Li, has contributed nearly US$4 billion to advancing education, medical research and services, and poverty alleviation across the USA, UK, Canada, and Asia. Recognizing the transformative potential of technological innovation in healthcare, the Foundation's latest gift to the University of Cambridge will build upon its previous donations of five Edison systems with three to Hong Kong, one to Singapore, and one recently to Stanford University. This new gift not only heralds the introduction of the first Edison system in the UK and Europe but also celebrates the enduring partnership between the Li Ka Shing Foundation and Cambridge in their collaborative efforts to fight cancer. By supporting cutting-edge medical technologies that can deliver low cost and highly efficient solutions, the Foundation hopes to enhance patient access with improved healthcare around the world. 'This donation is an historic milestone that brings non-invasive treatment of liver tumors using histotripsy to the UK,' said Mike Blue, President and CEO, HistoSonics. 'We are grateful to the Li Ka Shing Foundation for their visionary support. With Addenbrookes as our first NHS hospital site under UCNA, we are laying the foundation for future expansion into innovation driven hospitals across the UK.' The Edison System, which received FDA De Novo clearance in October 2023, uses non-invasive therapeutic focused ultrasound energy to mechanically destroy and liquefy targeted tissue and tumors without the invasiveness or toxicity of traditional procedures, reducing the risks of bleeding, infection, and damage to surrounding non-targeted tissue. HistoSonics' initial FDA clearance is for the destruction of liver tumors, with ongoing studies focusing on kidney tumors (HOPE4KIDNEY Trial NCT05820087) and pancreas tumors (GANNON Trial NCT06282809). Professor Deborah Prentice, Vice-Chancellor of the University of Cambridge, said: 'We are very fortunate that through the generosity of Sir Ka-shing Li, Addenbrooke's Hospital in Cambridge will be able to use cutting-edge histotripsy technology to improve outcomes for NHS patients. It is technology such as this that allows Cambridge to remain at the forefront of understanding and treating tumors, a position we aim to strengthen further with Cambridge Cancer Research Hospital.' With installations soon to be in five countries including the US, UK, Hong Kong, Singapore and the United Arab Emirates, HistoSonics is actively expanding access to its histotripsy platform and is working closely with clinical leaders, national health systems, and philanthropic partners to accelerate global adoption of histotripsy as a new category of health care. HistoSonics is also pursuing broader UK and European market access via CE marking. United Kingdom Intended Use Statement: The Edison System is intended for the non-invasive mechanical destruction of liver tumours, including the partial or complete destruction of unresectable liver tumours via histotripsy. This includes malignancy linked to primary liver cancer and cases of metastatic disease in the liver. The device should only be used by people who have completed training performed by HistoSonics Inc., and its use guided by the clinical judgement of an appropriately trained physician. Users must read this user guide to understand the warnings, precautions, and clinical trial summary, including reported adverse events. The Edison System has not been evaluated for the treatment of any specific disease, including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumour progression, 5-year survival or overall survival). United States Intended Use Statement: The Edison System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by physicians who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions, and a summary of clinical trial results, including reported adverse events. About HistoSonics HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, Michigan and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: For patient-related information please visit: View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.
